Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2021-05-31 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including specific share purchase numbers, prices, and transaction values. It references compliance with Market Abuse Regulation and provides detailed trading data. There is no indication of financial statements, earnings data, or management discussion. The content is focused on the company's repurchase of its own shares, which fits the category of a share repurchase or issuance transaction. The document length is substantial and contains detailed transaction data, not just a brief announcement or a report publication notice. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2021-05-31 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (488 characters) and explicitly states 'Please read the full announcement in the attached PDF'. It concerns 'Transactions under Novozymes s stock buyback program'. This structure—a brief announcement pointing to a separate, full document—fits the definition of a Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS) if RPA wasn't available. Since the topic is specifically about share transactions (buybacks), the most precise category is Transaction in Own Shares (POS). However, given the 'MENU VS MEAL' rule, where the text is just an announcement pointing to the full details, RPA is a strong candidate. Reviewing the definitions, POS is for the report of the transaction itself, while RPA is for the announcement of a report's publication. Since the text is clearly an announcement pointing to the actual details (the PDF), RPA is the most appropriate classification based on the provided rules, even though the subject matter relates to POS. If the document *was* the detailed transaction report, it would be POS. As it is just the notification, RPA applies.
2021-05-31 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a short announcement (488 characters) regarding a stock buyback program. It explicitly states 'Please read the full announcement in the attached PDF' and provides a link to the attachment. According to the 'Menu vs Meal' rule, this is an announcement of a report/transaction rather than the transaction report itself, and it specifically concerns the company buying back its own shares.
2021-05-25 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions under Novozymes' stock buyback program, providing accumulated figures, daily transaction volumes, average purchase prices, and detailed trade logs. This content directly relates to the company repurchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document is a detailed report, not just an announcement of a report, and its subject matter perfectly matches the POS definition.
2021-05-25 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing transactions under Novozymes' stock buyback program, including the number of shares repurchased, transaction values, and dates. It references compliance with the Market Abuse Regulation and provides detailed trading data. There is no indication of financial results, management discussion, or other report types. The content is focused on the company's repurchase of its own shares, which fits the definition of a Transaction in Own Shares (POS) filing. The document length is substantial and contains detailed transaction data, confirming it is not a mere announcement of a report but the actual transaction disclosure.
2021-05-17 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (488 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled 'Stock_Buybackprogram'. This indicates the document itself is merely an announcement about the availability of a report detailing transactions related to a stock buyback program. A stock buyback program falls under the category of the company buying back or selling its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). However, given the 'MENU VS MEAL' rule, since this is just an announcement pointing to the full details, it could also be considered a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since POS is a specific category for the *content* (share repurchase), and RPA/RNS is for the *act of announcing* the report, I must choose the most specific category that describes the underlying subject matter, which is POS, unless the announcement nature strongly overrides it. In this case, the subject is clearly 'Transactions under Novozymes’ stock buyback program'. If the document contained the transaction details, it would be POS. Since it only announces the availability of the details, RPA is a strong candidate. However, POS is the specific subject matter. Given the brevity and the instruction to point to an attachment, RPA is often used for such short announcements. Let's re-evaluate: POS is for the report of the transaction itself. This is an announcement *about* the report of the transaction. Therefore, RPA (Report Publication Announcement) is the best fit based on the 'MENU VS MEAL' rule, as it is announcing the publication of the detailed report.
2021-05-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.